EDN1 and Hypertension: The effectiveness of the ET-1 blockade suggests that this approach may result not only in the treatment of the systemic effects associated with PE (e.g., arterial hypertension), but also in protection from PODO injury, directly interacting with mechanisms of proteinuria [43].